Pharvaris NV (PHVS)
18.83
+0.17
(+0.91%)
USD |
NASDAQ |
Jun 18, 13:16
Pharvaris Cash from Financing (Quarterly): 0.8636M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.8636M |
| December 31, 2023 | 282.96M |
| September 30, 2023 | -0.2385M |
| June 30, 2023 | 69.61M |
| March 31, 2023 | -0.061M |
| December 31, 2022 | 0.2475M |
| September 30, 2022 | -0.5232M |
| June 30, 2022 | 9.522M |
| March 31, 2022 | -0.1236M |
| Date | Value |
|---|---|
| December 31, 2021 | -0.138M |
| September 30, 2021 | -3.788M |
| June 30, 2021 | 0.3906M |
| March 31, 2021 | 173.52M |
| December 31, 2020 | 75.53M |
| September 30, 2020 | 40.05M |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-3.788M
Minimum
Sep 2021
282.96M
Maximum
Dec 2023
38.11M
Average
0.2475M
Median
Dec 2022
Cash from Financing (Quarterly) Benchmarks
| uniQure NV | 0.00 |
| ProQR Therapeutics NV | -0.4551M |
| Merus NV | 30.16M |
| argenx SE | -- |
| Pharming Group | -2.471M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -26.32M |
| Cash from Investing (Quarterly) | -0.0334M |
| Free Cash Flow | -100.10M |
| Free Cash Flow Per Share (Quarterly) | -0.4897 |
| Free Cash Flow Yield | -11.83% |